Several other studies have suggested that the immune response of tumor cells can be modulated by fludarabine, paclitaxel and cyclophosphamide, by decreasing or depleting CD4+CD25+Foxp3+ Tregs [23–25]. Here, CD4 is linked to neoplasm.